SCOPUS 정보 검색 플랫폼

Journal of Heart Valve Disease

Volumn 16, Issue 2, 2007, Pages 200-202

Early mechanical mitral valve thrombosis in a patient with warfarin resistance

(4) Yasar, Ayse Saatci a Balbay, Yucel a Maden, Orhan a Sasmaz, Hatice a

a TURKIYE YUKSEK IHTISAS HOSPITAL (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ARTICLE; BIOPROSTHESIS; BLOOD; CASE REPORT; DRUG RESISTANCE; ECHOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MIDDLE AGED; MITRAL VALVE STENOSIS; REOPERATION; THROMBOSIS;

ANTICOAGULANTS; BIOPROSTHESIS; DRUG RESISTANCE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MIDDLE AGED; MITRAL VALVE STENOSIS; REOPERATION; THROMBOSIS; WARFARIN;

EID: 34347338900 PISSN: 09668519 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (3)

References (13)

1
- 0026432629
- Oral anticoagulant drugs
- Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991;324:1865-1875
- (1991) N Engl J Med , vol.324 , pp. 1865-1875
- Hirsh, J.¹

2
- 0018136725
- Mechanism of coumarin action: Significance of vitamin K epoxide reductase inhibition
- DOI 10.1021/bi00601a003
- Whitlon DS, Sadowski JA, Suttie JW. Mechanism of coumarin action. Significance of vitamin K epoxide reductase inhibition. Biochemistry 1978;17:1371-1377 (Pubitemid 8330368)
- (1978) Biochemistry , vol.17 , Issue.8 , pp. 1371-1377
- Whitlon, D.S.¹ Sadowski, J.A.² Suttie, J.W.³

3
- 0010982679
- O'Reilly RA, Aggeler PM, Hoag MS, Leong LS, Kropatkin ML. Hereditary transmission of exceptional resistance to coumarin anticoagulant drugs N Engl J Med 1964;271:809-815
- (1964) Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant Drugs N Engl J Med , vol.271 , pp. 809-815
- O'Reilly, R.A.¹ Aggeler, P.M.² Hoag, M.S.³ Leong, L.S.⁴ Kropatkin, M.L.⁵

4
- 0014962224
- The second reported kindred with hereditary resistance to oral anticoagulant drugs
- O'Reilly RA. The second reported kindred with hereditary resistance to oral anticoagulant drugs. N Engl J Med 1970;282:1448-1451
- (1970) N Engl J Med , vol.282 , pp. 1448-1451
- O'Reilly, R.A.¹

5
- 0020584625
- Familial warfarin resistance
- Holt RJ, Freytes CO. Familial warfarin resistance. Drug Intel Clin Pharm 1983;17:281-283 (Pubitemid 13079738)
- (1983) Drug Intelligence and Clinical Pharmacy , vol.17 , Issue.4 , pp. 281-283
- Holt, R.J.¹ Freytes, C.O.²

6
- 0346485982
- Hereditary warfarin resistance
- Lappegard KT. Hereditary warfarin resistance. Tidsskr Nor Laegeforen 2000;120:3257-3258
- (2000) Tidsskr Nor Laegeforen , vol.120 , pp. 3257-3258
- Lappegard, K.T.¹

7
- 0022978853
- Investigation of patients with abnormal response to warfarin
- Bentley DP, Backhouse G, Hutchings A, Haddon RL, Spragg B, Routledge PA. Investigation of patients with abnormal response to warfarin. Br T Clin Pharmacol 1986;22:37-41 (Pubitemid 17177202)
- (1986) British Journal of Clinical Pharmacology , vol.22 , Issue.1 , pp. 37-41
- Bentley, D.P.¹ Backhouse, G.² Hutchings, A.³

8
- 0023066672
- The biochemical basis of warfarin therapy
- Suttie JW. The biochemical basis of warfarin therapy. Adv Exp Med Biol 1987;214:3-16
- (1987) Adv Exp Med Biol , vol.214 , pp. 3-16
- Suttie, J.W.¹

9
- 0016259925
- The mode of action of vitamin K. Identification of γ- carboxyglutamic acid as a component of prothrombin
- Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin J Biol Chem 1974;249:6347-6350
- (1974) J Biol Chem , vol.249 , pp. 6347-6350
- Nelsestuen, G.L.¹ Zytkovicz, T.H.² Howard, J.B.³

10
- 0000376008
- Vitamin K-dependent modifications of glutamic acid residues in prothrombin
- Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K-dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974;71:2730-2733
- (1974) Proc Natl Acad Sci USA , vol.71 , pp. 2730-2733
- Stenflo, J.¹ Fernlund, P.² Egan, W.³ Roepstorff, P.⁴

11
- 10744228888
- Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
- DOI 10.1038/nature02214
- Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427:537-541 (Pubitemid 38209110)
- (2004) Nature , vol.427 , Issue.6974 , pp. 537-541
- Rost, S.¹ Fregin, A.² Ivaskevicius, V.³ Conzelmann, E.⁴ Hortnagel, K.⁵ Pelz, H.-J.⁶ Lappegard, K.⁷ Seifried, E.⁸ Scharrer, I.⁹ Tuddenham, E.G.D.¹⁰ Muller, C.R.¹¹ Strom, T.M.¹² Oldenburg, J.¹³

12
- 0019784833
- Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia
- Piroli RJ, Passanati GT, Shively CA, Vesell ES. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia. Clin Pharm Ther 1981;30:810-816 (Pubitemid 12198107)
- (1981) Clinical Pharmacology and Therapeutics , vol.30 , Issue.6 , pp. 810-816
- Piroli, R.J.¹ Passananti, G.T.² Shively, C.A.³ Vesell, E.S.⁴

13
- 0032711643
- Prosthetic heart valve thrombosis during dicloxacillin therapy
- Halvorsen S, Husebye T, Arnesen H. Prosthetic heart valve thrombosis during dicloxacillin therapy. Scand Cardiovasc J 1999;33:366-368
- (1999) Scand Cardiovasc J , vol.33 , pp. 366-368
- Halvorsen, S.¹ Husebye, T.² Arnesen, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.